School of Medicine
Showing 1-100 of 2,217 Results
-
Fahim Abbasi
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.
-
Suman Acharya
Postdoctoral Scholar, Immunology and Rheumatology
BioResearch focus: Immunology and Rheumatology, Immune metabolism
-
Ranjana Advani
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly InterestsClinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology. -
Patrick Cunningham Ahearn, MD, MAS
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ahearn is a board-certified nephrologist. He is also a clinical assistant professor in the Stanford University School of Medicine Division of Nephrology.
He specializes in providing innovative care to kidney disease and transplant patients. He develops a comprehensive, compassionate care plan personalized to each patient in his care.
In addition to his clinical practice, Dr. Ahearn has conducted research on barriers to transplantation for patients with extended dialysis exposure, disparities in living kidney donation, and disparities in access to kidney transplant. He also has researched kidney transplant outcomes as they relate to the timing of dialysis initiation plus new pharmaceuticals for the kidney transplant population.
Dr. Ahearn has made presentations on these and other topics to the American Transplant Congress and Society of General Internal Medicine Meeting. He has published peer-reviewed articles on his research topics in the Clinical Journal of the American Society of Nephrology, JAMA Network Open, American Journal of Kidney Diseases, American Journal of Surgery, and elsewhere. He has published abstracts in the Journal of the American Society of Nephrology.
Dr. Ahearn has earned honors for his research and scholarship. He has received research funding from the National Institute of Diabetes and Digestive and Kidney Diseases.
Among his honors, Dr. Ahearn was on the kidney transplant team that earned the Stanford Health Care Integrated Strategic Plan Star Award. The team was recognized for delivering excellence in patient care as well as for identifying opportunities to improve care.
He is a member of the American Society of Nephrology and American Society of Transplantation.
He has volunteered his time and expertise as a board member of the Village of Hope, a transitional housing program for homeless men, women, and children in Orange County, California. Dr. Ahearn has served as a volunteer and proctor at the free clinic providing medical services to the uninsured. -
Muhammad Abdelbasset Muhammad Ahmad
Postdoctoral Scholar, Infectious Diseases
BioPostdoctoral fellow, Department of Medicine, Stanford University (2022– Present).
PhD, Duke-National University of Singapore (2017 – 2021).
MSc, Faculty of Pharmacy, Cairo University (2014 – 2016).
BSc, Faculty of Pharmacy, Cairo University (2007 – 2012). -
Aijaz Ahmed, MD
Professor of Medicine (Gastroenterology and Hepatology)
BioDr. Ahmed is an internationally recognized hepatologist with expertise in the treatment of acute and chronic liver diseases. He is a board-certified specialist in gastroenterology and hepatology, transplant hepatology, and obesity medicine. Currently, he serves as the Medical Director of the Adult Liver Transplant Program at Stanford University.
Dr. Ahmed graduated from Dow Medical College, Karachi, Pakistan. He completed his residency training in Internal Medicine at Brown University, Providence, RI and fellowship training in Gastroenterology and Hepatology at Stanford University. During his fellowship, he focused on clinical and research training in General and Transplant Hepatology.
For patients under his care, Dr. Ahmed remains dedicated to creating a personalized, comprehensive, and above-all a compassionate treatment plan. He outlines the diagnostic and follow-up management pathway in an individualized fashion; he updates his patients and their family/support at each step of the decision-making process; and he focuses on prioritizing the wishes of his patients and their family/support for an optimal outcome and quality of life.
Dr. Ahmed remains clinically active and has been instrumental in establishing a wide network of hepatology outreach clinics in remote and underserved regions of California and Nevada.
In addition to his patient care responsibilities, Dr. Ahmed remains committed to the educational mission of Stanford ford University. He remains deeply interested in mentoring trainees and students al levels from undergraduates to trainee physicians and junior colleagues. Dr. Ahmed has received several teaching awards during his career.
Dr. Ahmed’s research interests include 1) multidisciplinary approach to nonalcoholic fatty liver disease (NAFLD), 2) disparities in the management of chronic liver disease, 3) improving screening and management of hepatocellular carcinoma (HCC), and 4) outcomes research in NAFLD, HCC, viral hepatitis, alcoholic liver disease, and liver transplantation. He heads a busy and productive outcomes research team. In addition, he collaborates with basic scientists and is participating in several translational research projects at Stanford University.
He has published his findings in textbooks, abstracts, case reports, and high- profile medical journals including Gastroenterology, Journal of Hepatology, Hepatology American Journal of Gastroenterology, and other well-renowned peer-reviewed publications.
Dr. Ahmed and his team has made presentations to his peers at many national and international conferences: the American Association for the Study of Liver Disease, International Liver Congress, European Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, and more. His presentations have addressed leading-edge approaches to the treatment of chronic liver disease, liver cancer, and liver failure. He also has presented his insights into the gastrointestinal impact of COVID-19.
For his clinical, research, and teaching achievements, Dr. Ahmed has earned extensive recognition. His honors include being named as one of America’s Top Physicians by the Consumers’ Research Council of America.
He is an active member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases. -
Neera Ahuja
Professor of Medicine (Hospital Medicine)
Current Research and Scholarly InterestsClinical inpatient trials, Quality improvement, Assessing interventions with operations on throughput. SDOH/Health equity
Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system -
Kevin M. Alexander, MD, FACC, FHFSA
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Alexander specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.
Dr. Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources. -
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials. -
Matthew S Alkaitis, MD PhD
Clinical Assistant Professor, Medicine
BioMatthew S Alkaitis MD, PhD is a Clinical Assistant Professor in the Division of Hospital medicine and Stanford School of Medicine. He received his PhD in biochemistry from the University of Oxford, in collaboration the National Institutes of Health as part of the NIH’s graduate partnership program. He received his MD from Harvard Medical school and completed his residency in internal medicine at Stanford. Dr. Alkaitis’ research interests span basic biochemistry, clinical informatics, natural language processing, genetics of hematologic malignancies and methods of cell-free DNA detection. His primary medical education interest is expanding accessibility of modern computational and bioinformatics techniques for clinical research.
-
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, and Senior Fellow at the Stanford Institute for HAI
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
-
Maryam Amirahmadi
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Maryam Amirahmadi is a microsurgery expert and postdoctoral research fellow at Stanford Cardiovascular Institute. She obtained her Doctor of Medicine (MD) degree from Hamadan University of Medical Sciences. After more than a year of experience as a Family and Emergency Physician, she spent around 4 years at the Department of Cardiovascular Surgery of Shiraz University of Medical Sciences where she served as a pediatric and adult Cardiac Intensive Care physician and received training in cardiovascular surgery at Namazi and Faghihi hospitals. She then spent a year in the Department of Vascular Surgery at the University of Miami, Miller School of Medicine, serving as a postdoctoral researcher and performing microsurgery on animals, with her research focused on therapeutic strategies to improve neovascularization after limb ischemia. Dr. Amirahmadi joined Stanford Cardiovascular Institute in 2022 where she is now a postdoctoral research fellow under the supervision of Prof. Philip S. Tsao, a renowned cardiovascular scientist. Her research interests and practical expertise include Microsurgery, and the effect of e-cigarette vaping on factors of inflammatory or immune pathways that can subsequently be related to the molecular mechanisms involved in angiogenesis and arteriogenesis in the murine model of hindlimb ischemia, as well as the mechanisms of e-cigarette and nicotine’s effects in augmenting Abdominal Aortic Aneurysm (AAA) in rodent models of aortic aneurysm, including porcine pancreatic elastase-induced AAA. Dr. Maryam Amirahmadi and her colleagues are currently investigating the transgenerational effects of vaping/nicotine on abdominal aortic aneurysm (AAA) risk.
-
Shuchi Anand
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsManagement of CKD and ESRD in low-resource settings
Tubulointerstitial disease
Chronic kidney disease of unknown etiology
ESRD and physical activity
ESRD and vitamin D deficiency -
Chad Anderson
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioChad Anderson is a Physician Assistant at Stanford ValleyCare and a Clinical Assistant Professor with the Stanford School of Medicine MSPA program. He is the Assistant Director of PA education at ValleyCare. He is dual credentialed as a Family Nurse Practitioner and a Physician Assistant. He completed his FNP/PA training at the Stanford School of Medicine and his graduate studies at A.T. Still University – Arizona School of Health Sciences. He is passionate about improving our patients hospital experience as well as educating our future providers.
-
Jason Andrews
Professor of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Justin P. Annes M.D., Ph.D.
Associate Professor of Medicine (Endocrinology)
On Partial Leave from 05/01/2024 To 08/31/2024Current Research and Scholarly InterestsThe ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders
DIABETES
The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.
(1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.
(2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.
HEREDIATY PARAGAGLIOMA SYNDROME
The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.
As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families. -
Sally Arai
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsResearch interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
-
Danit Ariel
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDanit Ariel, MD MS, is board certified in Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.
Dr. Ariel practices general endocrinology, with a special interest in menopause, LGBTQ+ health, transgender medicine, reproductive endocrinology and thyroid disorders amongst others.
She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.
Dr. Ariel is passionate about medical education and teaching, and serves on the teaching faculty in the Stanford University School of Medicine. She completed an honors certificate in medical education from Stanford. She is the Founding Director of the Student Guidance Program for medical students. Finally, within the division of Endocrinology, she is the Director of Faculty Wellness.
Appointments with with Dr. Ariel are available in the Hoover Pavilion on 211 Quarry Road as part of the Stanford Health Care Endocrinology Clinic and the Stanford Health Care LGBTQ+ Health Program. -
Julia Anne Armendariz
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have a passion for medical education and underserved patient communities, so my job at the Palo Alto VA suits me perfectly. I have the joy of being a course director for the Stanford Internal Medicine Medical Education Elective (along with Drs. Sharmin Shekarchian and Poonam Hosamani), which is one of my very favorite things in life. The best things about being a doctor are learning new things each day, bearing witness to the human experience of illness, and taking part in relieving suffering and promoting health within my community. My hobbies include anything outdoors, working in my garden, and baking up delicious treats.
-
Lucia Aronica
Casual - Non-Exempt, Medicine - Med/Stanford Prevention Research Center
BioFor over fifteen years, my research has focused on epigenetics - how environmental factors can influence gene activity and health outcomes. Unlike fixed genetics, epigenetic modifications are flexible and can store cellular memories from diet, stress, toxins, etc. This offers exciting potential for personalized health, as epigenetic markers can reveal susceptibility for exposure-driven diseases like obesity, diabetes, cardiovascular disease, and cancer.
I currently lead epigenetic analysis for the DIETFITS study by Dr. Christopher Gardner, the largest trial ever on low carb versus low fat diets for weight loss. My goal is to understand how weight loss alters gene activity through epigenetic changes, and whether these biomarkers can guide personalized diet strategies.
I also teach Nutritional Genomics at Stanford Continuing Studies, Stanford Sports Medicine, and the Stanford Center for Professional Development. As an award-winning science communicator, I use innovative formats like digital drawings to explain complex epigenetics concepts.
Additionally, I serve as an advisor to personal genomics companies, self-tracking technology startups, and investors in precision health research. I am passionate about translating epigenetics into practical lifestyle advice to optimize wellbeing. -
Anna Chen Arroyo
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Arroyo specializes in the treatment of allergic conditions including drug allergy and asthma. She has a special interest in understanding health and healthcare disparities in allergic diseases and how allergies change over a person's lifetime.
-
Maja Artandi, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Artandi is a Professor of Medicine in the Division of Primary Care and Population Health at Stanford. She is a leader in Primary Care, spearheading novel methods of health care delivery and education. She offers an impressive clinical background and has received several educational and leadership awards.
Her expertise lies in the development and implementation of a medical curriculum focused on the patient-physician interaction, emphasizing communication skills, physical examination skills and medical decision making to support best clinical practices.
Dr. Artandi is a dedicated Primary Care physician and educator and has served as a mentor for many students, residents and colleagues. She is currently the mentorship lead for the Division of Primary Care and Population Health.
She is in the process of getting an executive coaching certification and is faculty for the Advancing Communication Excellence at Stanford Program with the goal of helping her colleagues improve their communication skills.
From 2013-2021 she was the Co-Director of Primary Care education for the Stanford Internal Medicine residency program and co-founded and co-directed the Primary Care program (ACE) within the Stanford Internal Medicine Residency program.
Dr. Artandi is currently the Co-President of the Society of Bedside Medicine, an international society dedicated to studying and improving the patient/physician interaction.
She is a fellow of the Royal College of Physicians Edinburgh and of the American College of Physicians and currently serves as the Wellness chair for the Northern California ACP chapter. -
Steven Artandi, MD, PhD
Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
-
Ronan Arthur
Postdoctoral Scholar, Infectious Diseases
BioRonan Arthur (PhD) is a postdoctoral scholar in the Stanford School of Medicine and in the Department of Biology. Ronan studies adaptive behavior and community trust during epidemics through mathematical modeling techniques and empirical work in Liberia. Current research includes: hospital hand hygiene in Liberia; hospital ventilation in rural Liberia; adaptive behavior during epidemics with age-structure; quantifying gene-culture co-evolution; trust of government and health system during COVID-19 in Liberia; and agent-based modeling of COVID-19 and Ebola Virus Disease.
-
Steven Asch
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsDescribe your current research interest and activities
-
Euan A. Ashley
Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Mukta Awasthi
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have been an academic hospitalist for over twenty years, and currently work at the Veterans Affairs Medical Center in Palo Alto where I serve as teaching faculty for Stanford medicine residents and students. I am currently Medical Director of the Intermediate Intensive Care Unit (IICU). I am passionate about delivering quality medical care and my interests include Process Improvement , Narrative Medicine, Medical Education.
-
Mehrdad Ayati
Adjunct Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Ayati completed his residency at UC Davis and his fellowship at Stanford University. During his residency at UC Davis, Dr. Ayati received the Award of Excellence in Clinical Teaching. Dr. Ayati worked at hospitals such as Lodi Memorial Hospital in Lodi, California, and as an Emergency Medicine Attending at Veteran Affairs in Palo Alto, California. Dr. Ayati worked as a Stanford Medical Director at Los Altos and Palo Alto Subacute and Rehabilitation centers and he is currently serving as a medical advisor for many Skilled Nursing facilities and also memory care units and assisted living facilities in Northen California. Dr. Ayati has a broad spectrum of practice and knowledge of general medicine and primary care in various settings, from office to Emergency room and acute and Sub-acute care. Dr. Ayati’s main areas of research and clinical focus are in the physiology of aging and on finding practical and yet innovative ways of addressing the wellbeing and needs of the population in any age category. Dr. Ayati is an advocate of his patient’s physical and mental health at any age in addition to disease management and prevention. Dr. Ayati is currently a member of the Ethnogeriatric and Quality and Policy Performance Committees of the Americal Geraitric Society. He also serves as a Community Health Advisor for Alzheimer Association, Northen California and Nevada Chapter. Dr. Ayati is the author of “Paths to Healthy Aging”. Dr. Ayati is also a guest educational speaker on several radio stations such as National Public Radio (NPR) and San Francisco’s KQED and international and national conferences. He also testified in the Senate of the US, Special Committee of Aging in 2018 to address the challenges of aging populations in the US.
Dr. Ayati strives to provide reliable information, effective strategies, and simple guidelines for patients of all ages to avoid or manage chronic diseases and to have a significantly better quality of life.
Dr. Ayati’s main focus and passion are in:
Raising awareness about Over Medication and Drug Cascade issues in the elderly population as well as highlighting prevention strategies
Helping patients better understand and voice their end of life care choices and medical intervention wishes
Bringing into focus the numerous social, economical, political and health challenges and hardship the elderly face in our society as well as finding solutions to address their needs
Being the voice of the elderly in finding innovative and yet practical solutions to promote their physical and mental health and well being -
Zahra Azizi
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a medical doctor and clinical epidemiologist, presently serving as a scientist at Stanford University. My work centers on precision medicine, employing digital health, computer science, and artificial intelligence (AI) techniques. I am dedicated to integrating and applying these methodologies within the medical field to generate novel insights and deepen understanding of health-related issues. My focus also extends to tackling health disparities, with the ultimate goal of enhancing patient care and reducing disease impact.
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda.
-
Adrian Matias Bacong
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsAdrian M. Bacong, PhD, MPH is a social epidemiologist by training. His research seeks to identify social and structural factors that underlie health inequities by race, ethnicity, and immigration status. Specifically, his work has explored the role of socioeconomic factors in explaining health disparities by immigrant legal status and visa type. Furthermore, Adrian is interested in the effects of immigration on health. He received a NIH F31 award (1F31MD015931-01A1) to examine factors affecting the health of Filipino migrants to the U.S. compared to Filipinos remaining in the Philippines.
Adrian has also examined the intersections of race, ethnicity, and immigration status among older adults. Finally, Adrian written upon the role of data disaggregation as a method of public health critical race praxis. Currently, Adrian is researching the role of social and policy level factors underlying health disparities among immigrants. -
Cameron Scott Bader
Postdoctoral Scholar, Bone Marrow Transplantation
BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.
-
Adi badhwar
Masters Student in Clinical Informatics Management, admitted Summer 2022
BioBuilding healthcare technology products powered by deep-learning & big data from concept to scale
